The test is the first in a proposed line of assays that will run on the GeneXpress platform with run times of around 30 minutes.
The firm said that molecular product sales were up 103 percent, driven by the launch of the Solana Group A Strep assay earlier this year.
The real-time PCR-based test runs on the BD Max system and comes in a single tube that snaps into the BD MAX extraction cartridge.
The test runs on the company's Solana instrument, which can process up to 12 patient samples in a 45-minute run.
The investment bank said it has heard positive feedback from early adopters in Europe of GenMark's ePlex system and respiratory panel.
The Alere flu test detected fewer cases of influenza A in a recent study, which researchers attributed to low viral loads.
Although the financial filing sheds increased light on Alere's business, the company is asking for an extension to file its second quarter financial statements.
The PCR-based assays run on the company's Aries system, which itself received FDA clearance in October 2015.
A month after Brexit fears pushed the GenomeWeb Index down half a percent, companies rallied on news of an acquisition and better than expected Q2 performances.
The point-of-care test detects and distinguishes influenza A and B as well as respiratory syncytial virus in about 20 minutes.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.